Educational Disclaimer: This article is for informational and educational purposes only. It does not constitute medical advice, laboratory protocol, or product recommendation. Consult a licensed healthcare provider before making any health decisions.

How to Read a Certificate of Analysis (COA) for Research Peptides

A Certificate of Analysis is the single most important quality document attached to a research peptide. It tells you what's actually in the vial — or, more precisely, what a testing laboratory measured. If you're sourcing peptides for research, knowing how to read a COA is the difference between trusting a number on a label and understanding what that number means.

This guide breaks down every section of a standard peptide COA, explains the analytical methods behind the results, and identifies the red flags that suggest a document may not be trustworthy.

What Is a Certificate of Analysis?

A Certificate of Analysis (COA) is a document issued by a manufacturer or an independent testing laboratory that reports the results of quality-control testing performed on a specific batch of material. For research peptides, a COA typically includes:

• Identity confirmation — verifying the compound is what it claims to be
• Purity measurement — quantifying how much of the sample is the target peptide versus impurities
• Contamination screening — testing for endotoxins, bioburden, residual solvents, or heavy metals
• Physical characteristics — appearance, solubility, pH

A properly issued COA is batch-specific. It should reference a unique lot number that corresponds to the exact batch you received. A COA without a lot number, or one that appears identical across multiple batches, is a significant red flag.

For Research Use Only (RUO). Products referenced in this article are intended for laboratory and research applications only. COA interpretation discussed here applies to evaluating research-grade materials.

Section 1: Header Information

The top of a COA contains identifying information. Here's what to look for:

Product Name and Catalog Number

The peptide should be identified by its standard name (e.g., "BPC-157 Fragment," "CJC-1295 DAC") and a catalog or product number. Cross-reference this with what you ordered.

Lot / Batch Number

Every COA must reference a specific lot number. This is the traceability link between the document and the physical material. If your vial's lot number does not match the COA, the document does not apply to your product.

Date of Manufacture and Expiration

Manufacturing and expiration dates establish the window in which the product was tested and remains within specification. Peptides degrade over time, especially if improperly stored — a COA from 18 months ago may no longer reflect current purity.

Issuing Laboratory

Note whether the COA was issued by the manufacturer's in-house laboratory or by an independent third-party lab. Third-party testing from an accredited laboratory (ISO 17025 or equivalent) carries significantly more weight than self-reported results.

Section 2: Identity Testing — Is This the Right Peptide?

Identity testing answers a simple question: Is this compound actually what the label says it is?

Mass Spectrometry (MS)

Mass spectrometry is the gold standard for identity confirmation. It measures the molecular weight of the peptide and compares it to the theoretical molecular weight based on the amino acid sequence.

What to look for on the COA:

Field: What It Means

Observed MW: The molecular weight measured by the instrument

Theoretical MW: The expected molecular weight based on the known sequence

Method: Usually ESI-MS (electrospray ionization) or MALDI-TOF

The observed and theoretical values should match closely. For most research peptides, a deviation of less than ±1 Da (Dalton) is expected. Larger deviations may indicate:

• A synthesis error (wrong amino acid incorporated)
• Partial degradation
• An entirely different compound

If a COA lacks mass spectrometry data, identity has not been independently confirmed. Purity data alone does not tell you what the compound is — only how pure it is.

Amino Acid Sequence Verification

Some COAs include amino acid analysis (AAA) or sequencing data, particularly for longer peptides. This provides additional identity confirmation beyond molecular weight by verifying the actual sequence of amino acids.

Section 3: Purity Testing — How Pure Is It?

Purity is the most-referenced number on a COA, and the most frequently misunderstood. A purity value tells you the percentage of the sample that is the target peptide versus related impurities (typically truncated sequences, deletion peptides, or oxidized variants from synthesis).

High-Performance Liquid Chromatography (HPLC)

HPLC is the primary analytical method for peptide purity determination. The technique separates compounds based on their chemical properties, producing a chromatogram — a graph where each peak represents a different component of the sample.

What to look for on the COA:

Field: What It Means

Purity (%): The area percentage of the main peptide peak relative to all detected peaks

Method: Usually RP-HPLC (reversed-phase) with C18 column

Detection: Typically UV at 220 nm

Retention Time: The time at which the main peptide elutes; should be consistent with reference standards

Column & Conditions: Specific column type, mobile phase, gradient — important for reproducibility

Understanding Purity Grades

Purity Level: Typical Application

>98%: High-purity research, binding assays, cell-based studies

95–98%: General research applications

<95%: May require additional purification before use in sensitive assays

Key nuance: HPLC purity is relative purity — it measures the target peak as a percentage of all UV-absorbing peaks. It does not account for non-UV-absorbing contaminants (such as salts, water content, or residual solvents). A peptide with 99% HPLC purity might still contain 10% water and 5% acetate salt by total mass. This is normal and expected for lyophilized peptides, but it means HPLC purity and absolute purity are different numbers.

Chromatogram: The Most Valuable Part of the COA

If the COA includes an actual HPLC chromatogram (the graph itself, not just the number), you can evaluate:

• Peak shape — A sharp, symmetrical main peak indicates good separation and a well-characterized compound. Broad or tailing peaks may indicate co-eluting impurities.
• Baseline noise — A clean, flat baseline suggests a well-maintained instrument and clean sample. Noisy baselines can obscure minor impurities.
• Minor peaks — Small peaks flanking the main peak are typically related impurities (truncated sequences, oxidized forms). Their size relative to the main peak determines the reported purity.

A COA that reports a purity number without an accompanying chromatogram provides less verifiable information. The chromatogram is the raw evidence; the purity number is the interpretation.

Section 4: Contamination Testing

Beyond identity and purity, a comprehensive COA should report on potential contaminants that could affect research outcomes.

Endotoxin Testing (LAL Test)

Endotoxins are lipopolysaccharides from gram-negative bacteria. Even trace amounts can confound cell-based research by activating immune signaling pathways independent of the peptide being studied.

What to look for:

Field: What It Means

Result: Reported in Endotoxin Units per milligram (EU/mg)

Method: Limulus Amebocyte Lysate (LAL) — gel clot, turbidimetric, or chromogenic

Specification: Typically <1 EU/mg for research-grade peptides

Why it matters for research: If you're running cell-based assays or in vivo studies and your peptide has high endotoxin levels, your results may reflect endotoxin-driven inflammation rather than peptide activity. This is one of the most commonly overlooked sources of experimental confounding in peptide research.

Bioburden / Sterility Testing

Some COAs report total aerobic microbial count (TAMC) and total yeast/mold count (TYMC). These values indicate whether the manufacturing environment maintained appropriate microbial controls.

Residual Solvent Analysis

Peptide synthesis and purification involve organic solvents (acetonitrile, TFA, DMF, etc.). Residual solvent analysis — typically by gas chromatography (GC) — confirms these are below established limits (ICH Q3C guidelines).

Solvent: ICH Class | Limit (ppm)

Acetonitrile: 2 | 410

TFA (trifluoroacetic acid): — | Reported as counterion content

DMF (dimethylformamide): 2 | 880

Heavy Metals Testing

Some COAs include ICP-MS (inductively coupled plasma mass spectrometry) results for heavy metals such as lead, arsenic, mercury, and cadmium. While not universally reported for research peptides, this testing provides additional safety characterization of the material.

Section 5: Physical Characteristics

Appearance

A simple visual description — typically "white to off-white lyophilized powder" for most peptides. Significant color changes (yellowing, browning) may indicate degradation or contamination.

Solubility

Some COAs note recommended reconstitution solvents and expected solubility ranges. This is practical information for laboratory use.

pH

If the peptide is supplied in solution, pH should be reported. Peptide stability is pH-dependent, and working outside the optimal range accelerates degradation.

Water Content (Karl Fischer)

Karl Fischer titration measures residual water content in lyophilized peptides. Typical values range from 2–8%. High water content can accelerate degradation during storage.

Section 6: Specifications vs. Results

A well-structured COA presents both the specification (the acceptable range) and the result (what was actually measured) for each test:

Test: Specification | Result

Appearance: White to off-white powder | White powder

HPLC Purity: ≥98.0% | 99.2%

MS (MW): 1419.5 ± 1.0 Da | 1419.6 Da

Endotoxin: <1.0 EU/mg | <0.1 EU/mg

Water Content: ≤8.0% | 3.2%

This format allows you to immediately see whether each result falls within the acceptable range. A COA that reports results without specifications gives you no framework for evaluating whether the results are acceptable.

Red Flags: When to Question a COA

Not all COAs are created equal. Watch for these warning signs:

1. No Lot Number

A COA without a batch-specific lot number cannot be tied to your specific product. It may be a generic template.

2. No Mass Spectrometry Data

Without MS confirmation, you have purity data for an unidentified compound. HPLC tells you how pure something is; MS tells you what it is.

3. Identical COAs Across Batches

If multiple batches share identical results (same purity to the decimal, same retention time, same everything), the COA may have been duplicated rather than generated from actual testing.

4. No Chromatogram

A purity number without the supporting chromatogram is an assertion without evidence.

5. Self-Tested Only

Results from the manufacturer's own lab, with no third-party verification, carry less weight. Look for independent lab accreditation (ISO 17025).

6. Missing Contamination Data

A COA that reports only purity and identity, with no endotoxin, solvent, or bioburden data, provides an incomplete picture of material quality.

7. Unrealistically High Purity

Consistent claims of >99.9% purity across multiple peptides and batches should be viewed skeptically. Analytical methods have inherent variability, and reporting at that precision requires extraordinary instrument calibration and methodology.

8. Outdated Testing

If the COA testing date is more than 12 months before your receipt, the results may no longer reflect the current state of the material, particularly if storage conditions were suboptimal.

How to Verify a COA Independently

If you have the resources and the research application demands it:

1. Request the raw data — Ask the supplier for the actual chromatogram and mass spectrum, not just summary numbers.
2. Cross-reference the testing lab — Verify that the named laboratory exists and holds relevant accreditations.
3. Compare across suppliers — If multiple vendors sell the same peptide sequence, COA results should be broadly comparable for similar purity grades.
4. Run your own verification — For critical research, consider running independent HPLC and MS analysis on received material.

Glossary of Common COA Terms

Term: Definition

HPLC: High-Performance Liquid Chromatography — the primary method for measuring peptide purity

RP-HPLC: Reversed-Phase HPLC — the most common HPLC mode for peptides

ESI-MS: Electrospray Ionization Mass Spectrometry — used for peptide identity confirmation

MALDI-TOF: Matrix-Assisted Laser Desorption/Ionization Time-of-Flight — alternative MS method

MW / Da: Molecular Weight / Dalton — the unit of molecular mass

LAL: Limulus Amebocyte Lysate — the standard endotoxin detection assay

EU/mg: Endotoxin Units per milligram

TFA: Trifluoroacetic acid — a common counterion in synthetic peptides

Karl Fischer: A titration method for measuring water content

ICH Q3C: International Council for Harmonisation guideline for residual solvents

ISO 17025: International standard for testing and calibration laboratory competence

LOD: Limit of Detection — the lowest concentration an analytical method can reliably detect

LOQ: Limit of Quantitation — the lowest concentration that can be quantitatively measured with acceptable precision

Summary

A Certificate of Analysis is only as valuable as your ability to interpret it. The key takeaways:

• Identity first. Mass spectrometry confirms what the compound is. Without it, purity data is meaningless.
• Purity is relative. HPLC purity measures peptide content relative to detectable impurities — not absolute composition.
• Contamination matters. Endotoxin, solvent, and bioburden data protect the integrity of downstream research.
• The chromatogram is the evidence. Numbers are summaries; raw analytical data is proof.
• Lot numbers are non-negotiable. A COA that doesn't match your batch doesn't apply to your batch.
• Third-party testing adds credibility. Independent verification from an accredited lab is the highest standard.

Understanding these principles allows researchers to make informed sourcing decisions and maintain the rigor that credible research demands.

References

1. International Council for Harmonisation (ICH). "Q3C(R8) Impurities: Guideline for Residual Solvents." ICH, 2021. https://www.ich.org/page/quality-guidelines (https://www.ich.org/page/quality-guidelines)
2. United States Pharmacopeia (USP). "Chapter <85> Bacterial Endotoxins Test." USP-NF, 2023.
3. United States Pharmacopeia (USP). "Chapter <621> Chromatography." USP-NF, 2023.
4. Zeng, K., Vanhoutte, K., Gotti, C., et al. "Liquid Chromatography-High Resolution Mass Spectrometry for Peptide Drug Quality Control." AAPS Journal, 2015. https://pubmed.ncbi.nlm.nih.gov/25716148/ (https://pubmed.ncbi.nlm.nih.gov/25716148/)
5. International Council for Harmonisation (ICH). "Q2(R1) Validation of Analytical Procedures: Text and Methodology." ICH, 2005. https://www.ich.org/page/quality-guidelines (https://www.ich.org/page/quality-guidelines)
6. ISO/IEC 17025:2017. "General requirements for the competence of testing and calibration laboratories." International Organization for Standardization.
7. Fekete, S., Veuthey, J.-L., & Guillarme, D. "New trends in reversed-phase analytical liquid chromatography of peptides and proteins." Journal of Pharmaceutical and Biomedical Analysis, 69, 9–27, 2012. https://doi.org/10.1016/j.jpba.2012.03.024 (https://doi.org/10.1016/j.jpba.2012.03.024)
8. Mant, C. T., & Hodges, R. S. "HPLC analysis and purification of peptides." Methods in Molecular Biology, 2007. https://pubmed.ncbi.nlm.nih.gov/18604941/ (https://pubmed.ncbi.nlm.nih.gov/18604941/)

This article is for informational and educational purposes only. It does not constitute medical advice. Products discussed are intended for research use only and are not intended for human consumption. Consult a licensed healthcare provider before making any health decisions.